ReviewEndocrine, metabolic & immune disorders drug targets2026

Improving Immune Checkpoint Therapy in the Tumor Microenvironment by Targeting T Cell Metabolism.

Jun Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.